Unknown residue CXM: ATOM 1 N CXM 1 22.059 20.546 49.246 1.00 26.25 N Unknown residue CXM: ATOM 2 CA CXM 1 23.325 20.930 49.649 1.00 26.46 C Unknown residue CXM: ATOM 3 CB CXM 1 24.408 20.648 48.559 1.00 25.91 C Unknown residue CXM: ATOM 4 CG CXM 1 24.709 19.177 48.360 1.00 23.83 C Unknown residue CXM: ATOM 5 SD CXM 1 25.715 18.716 46.949 1.00 24.36 S Unknown residue CXM: ATOM 6 CE CXM 1 24.764 19.064 45.501 1.00 22.38 C Unknown residue CXM: ATOM 7 C CXM 1 23.347 22.469 49.769 1.00 27.93 C Unknown residue CXM: ATOM 8 O CXM 1 22.538 23.187 49.111 1.00 26.69 O Unknown residue CXM: ATOM 9 CN CXM 1 21.592 19.646 50.161 1.00 26.66 C Unknown residue CXM: ATOM 10 ON1 CXM 1 22.213 18.620 50.504 1.00 28.21 O Unknown residue CXM: ATOM 11 ON2 CXM 1 20.634 19.130 49.587 1.00 25.37 O Unresolved disorder model. using A ATOM 1211 CG APHE 149 30.693 24.251 26.807 0.50 29.69 C Unresolved disorder model. using A ATOM 1212 CG BPHE 149 31.655 23.508 26.232 0.50 26.38 C Unresolved disorder model. using A ATOM 1213 CD1APHE 149 29.878 25.339 26.515 0.50 29.64 C Unresolved disorder model. using A ATOM 1214 CD1BPHE 149 32.425 23.907 27.311 0.50 25.53 C Unresolved disorder model. using A ATOM 1215 CD2APHE 149 31.930 24.482 27.398 0.50 29.61 C Unresolved disorder model. using A ATOM 1216 CD2BPHE 149 32.129 23.784 24.964 0.50 25.12 C Unresolved disorder model. using A ATOM 1217 CE1APHE 149 30.263 26.623 26.842 0.50 29.23 C Unresolved disorder model. using A ATOM 1218 CE1BPHE 149 33.669 24.478 27.120 0.50 25.69 C Unresolved disorder model. using A ATOM 1219 CE2APHE 149 32.318 25.762 27.746 0.50 30.15 C Unresolved disorder model. using A ATOM 1220 CE2BPHE 149 33.371 24.352 24.770 0.50 24.84 C Unresolved disorder model. using A ATOM 1221 CZ APHE 149 31.479 26.824 27.457 0.50 30.83 C Unresolved disorder model. using A ATOM 1222 CZ BPHE 149 34.149 24.704 25.852 0.50 24.08 C Unresolved disorder model. using A ATOM 2009 CG AGLU 245 28.597 -4.724 39.124 0.50 33.99 C Unresolved disorder model. using A ATOM 2010 CG BGLU 245 26.477 -4.749 40.014 0.50 33.46 C Unresolved disorder model. using A ATOM 2011 CD AGLU 245 28.482 -6.233 39.035 0.50 34.43 C Unresolved disorder model. using A ATOM 2012 CD BGLU 245 25.920 -4.603 38.619 0.50 34.58 C Unresolved disorder model. using A ATOM 2013 OE1AGLU 245 27.636 -6.845 39.718 0.50 34.70 O Unresolved disorder model. using A ATOM 2014 OE1BGLU 245 26.670 -4.439 37.622 0.50 33.87 O Unresolved disorder model. using A ATOM 2015 OE2AGLU 245 29.259 -6.827 38.262 0.50 34.28 O Unresolved disorder model. using A ATOM 2016 OE2BGLU 245 24.663 -4.635 38.533 0.50 35.61 O Unknown residue CXM: ATOM 2151 N CXM 263 39.023 47.760 36.419 1.00 35.26 N Unknown residue CXM: ATOM 2152 CA CXM 263 37.629 47.657 36.752 1.00 33.83 C Unknown residue CXM: ATOM 2153 CB CXM 263 36.756 46.958 35.721 1.00 34.00 C Unknown residue CXM: ATOM 2154 CG CXM 263 36.427 47.824 34.513 1.00 32.61 C Unknown residue CXM: ATOM 2155 SD CXM 263 35.293 46.981 33.405 1.00 31.14 S Unknown residue CXM: ATOM 2156 CE CXM 263 36.322 45.647 32.789 1.00 31.90 C Unknown residue CXM: ATOM 2157 C CXM 263 37.654 46.863 38.063 1.00 33.75 C Unknown residue CXM: ATOM 2158 O CXM 263 38.484 45.923 38.206 1.00 32.47 O Unknown residue CXM: ATOM 2159 CN CXM 263 39.492 48.968 36.050 1.00 37.35 C Unknown residue CXM: ATOM 2160 ON1 CXM 263 38.637 49.909 35.890 1.00 33.27 O Unknown residue CXM: ATOM 2161 ON2 CXM 263 39.104 49.325 34.931 1.00 39.14 O Unresolved disorder model. using A ATOM 2176 CG AGLN 265 33.406 42.292 39.498 0.50 28.76 C Unresolved disorder model. using A ATOM 2177 CG BGLN 265 33.242 43.046 38.862 0.50 29.25 C Unresolved disorder model. using A ATOM 2178 CD AGLN 265 32.118 42.079 38.738 0.50 28.89 C Unresolved disorder model. using A ATOM 2179 CD BGLN 265 32.885 44.284 38.068 0.50 29.59 C Unresolved disorder model. using A ATOM 2180 OE1AGLN 265 31.609 40.959 38.698 0.50 29.10 O Unresolved disorder model. using A ATOM 2181 OE1BGLN 265 33.513 45.349 38.144 0.50 26.99 O Unresolved disorder model. using A ATOM 2182 NE2AGLN 265 31.637 43.143 38.110 0.50 28.38 N Unresolved disorder model. using A ATOM 2183 NE2BGLN 265 31.777 44.180 37.309 0.50 30.12 N Unresolved disorder model. using A ATOM 3294 CG AASP 401 43.410 18.530 14.553 0.50 39.85 C Unresolved disorder model. using A ATOM 3295 CG BASP 401 42.168 18.969 12.236 0.50 39.33 C Unresolved disorder model. using A ATOM 3296 OD1AASP 401 43.413 19.078 15.677 0.50 39.90 O Unresolved disorder model. using A ATOM 3297 OD1BASP 401 41.219 19.715 11.912 0.50 40.16 O Unresolved disorder model. using A ATOM 3298 OD2AASP 401 43.649 17.305 14.427 0.50 40.68 O Unresolved disorder model. using A ATOM 3299 OD2BASP 401 42.333 17.860 11.684 0.50 39.76 O Unresolved disorder model. using A ATOM 3368 CG APHE 411 30.894 27.833 24.916 0.50 34.20 C Unresolved disorder model. using A ATOM 3369 CG BPHE 411 29.227 28.025 24.004 0.50 29.17 C Unresolved disorder model. using A ATOM 3370 CD1APHE 411 31.758 26.747 24.911 0.50 35.83 C Unresolved disorder model. using A ATOM 3371 CD1BPHE 411 28.463 28.545 25.024 0.50 28.70 C Unresolved disorder model. using A ATOM 3372 CD2APHE 411 30.333 28.195 26.124 0.50 36.30 C Unresolved disorder model. using A ATOM 3373 CD2BPHE 411 28.704 26.945 23.291 0.50 29.95 C Unresolved disorder model. using A ATOM 3374 CE1APHE 411 32.068 26.057 26.071 0.50 36.56 C Unresolved disorder model. using A ATOM 3375 CE1BPHE 411 27.187 28.062 25.273 0.50 28.36 C Unresolved disorder model. using A ATOM 3376 CE2APHE 411 30.630 27.524 27.294 0.50 37.11 C Unresolved disorder model. using A ATOM 3377 CE2BPHE 411 27.445 26.431 23.545 0.50 28.71 C Unresolved disorder model. using A ATOM 3378 CZ APHE 411 31.498 26.452 27.259 0.50 37.36 C Unresolved disorder model. using A ATOM 3379 CZ BPHE 411 26.700 26.991 24.565 0.50 28.93 C 1